TrialSite recently announced that China’s state-owned Sinopharm recently benefited from the conditional approval of its inactivated vaccine candidate targeting COVID-19. The Chinese and the Russians have…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.